4//SEC Filing
Bode John B 4
Accession 0001437749-23-013121
CIK 0001434647other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 9:44 PM ET
Size
6.3 KB
Accession
0001437749-23-013121
Insider Transaction Report
Form 4
Bode John B
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-03+58,800→ 58,800 totalExercise: $4.97Exp: 2033-05-02→ Common Stock (58,800 underlying)
Footnotes (3)
- [F1]The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 3, 2023.
- [F2]This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy.
- [F3]33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001612084
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 9:44 PM ET
- Size
- 6.3 KB